Evolutionary and functional analyses of LRP5 in archaic and extant modern humans.


Journal

Human genomics
ISSN: 1479-7364
Titre abrégé: Hum Genomics
Pays: England
ID NLM: 101202210

Informations de publication

Date de publication:
27 May 2024
Historique:
received: 02 02 2024
accepted: 07 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 27 5 2024
Statut: epublish

Résumé

The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced. We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation. In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations.

Sections du résumé

BACKGROUND BACKGROUND
The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced.
RESULTS RESULTS
We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation.
CONCLUSIONS CONCLUSIONS
In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations.

Identifiants

pubmed: 38802968
doi: 10.1186/s40246-024-00616-6
pii: 10.1186/s40246-024-00616-6
doi:

Substances chimiques

Low Density Lipoprotein Receptor-Related Protein-5 0
LRP5 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Subventions

Organisme : Ministerio de Ciencia e Innovación
ID : SAF 2016-75948R and PID2019-107188RB-C21
Organisme : Generalitat de Catalunya
ID : GRC 2017 SGR 937
Organisme : Catalan Government
ID : 2017SGR:00738
Organisme : Ministerio de Economía y Competitividad
ID : PGC2018-098574-B-I00

Informations de copyright

© 2024. The Author(s).

Références

Chirchir H, Kivell TL, Ruff CB, Hublin JJ, Carlson KJ, Zipfel B, et al. Recent origin of low trabecular bone density in modern humans. Proc Natl Acad Sci U S A. 2015;112(2):366–71.
pubmed: 25535354 doi: 10.1073/pnas.1411696112
Harvati K, Reyes-Centeno H. Evolution of homo in the middle and late pleistocene. J Hum Evol. 2022;173:103279. https://doi.org/10.1016/j.jhevol.2022.103279 .
doi: 10.1016/j.jhevol.2022.103279 pubmed: 36375244
Gómez-Robles A. Dental evolutionary rates and its implications for the Neanderthal–modern human divergence. Sci Adv. 2019;5(5):eaaw1268. https://doi.org/10.1126/sciadv.aaw1268 .
doi: 10.1126/sciadv.aaw1268 pubmed: 31106274 pmcid: 6520022
Weaver TD. The meaning of Neandertal skeletal morphology. Proc Natl Acad Sci U S A. 2009;106(38):16028–33. https://doi.org/10.1073/pnas.0903864106 .
doi: 10.1073/pnas.0903864106 pubmed: 19805258 pmcid: 2752516
Ruff CB, Trinkaus E, Walker A, Larsen CS. Postcranial robusticity in Homo. I: Temporal trends and mechanical interpretation. Am J Phys Anthropol. 1993;91(1):21–53. https://doi.org/10.1002/ajpa.1330910103 .
doi: 10.1002/ajpa.1330910103 pubmed: 8512053
Kralick AE, Zemel BS. Evolutionary perspectives on the developing skeleton and implications for lifelong health. Front Endocrinol (Lausanne). 2020;11:513066. https://doi.org/10.3389/fendo.2020.00099 .
doi: 10.3389/fendo.2020.00099
Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporosis Int. 2003;14(Suppl 3):13–8. https://doi.org/10.1007/s00198-002-1345-4 .
doi: 10.1007/s00198-002-1345-4
Ruff CB, Holt B, Niskanen M, Sladek V, Berner M, Garofalo E, et al. Gradual decline in mobility with the adoption of food production in Europe. Proc Natl Acad Sci U S A. 2015;112(23):7147–52. https://doi.org/10.1073/pnas.1502932112
doi: 10.1073/pnas.1502932112 pubmed: 26060299 pmcid: 4466732
Ryan TM, Shaw CN. Gracility of the modern Homo sapiens skeleton is the result of decreased biomechanical loading. Proc Natl Acad Sci U S A. 2015;112(2):372–7.
pubmed: 25535352 doi: 10.1073/pnas.1418646112
Chirchir H. Trabecular bone fraction variation in modern humans, fossil hominins and other primates. Anatom Rec (Hoboken). 2019;302(2):288–305.
doi: 10.1002/ar.23967
Polidoulis I, Beyene J, Cheung AM. The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women–a systematic review and meta-analysis of randomized controlled trials. Osteoporosis Int. 2012;23(1):39–51.
doi: 10.1007/s00198-011-1734-7
Warden SJ, Mantila Roosa SM, Kersh ME, Hurd AL, Fleisig GS, Pandy MG, et al. Physical activity when young provides lifelong benefits to cortical bone size and strength in men. Proc Natl Acad Sci U S A. 2014;111(14):5337–42.
pubmed: 24706816 pmcid: 3986122 doi: 10.1073/pnas.1321605111
Macintosh AA, Wells JCK, Stock JT. Maternal investment, maturational rate of the offspring and mechanical competence of the adult female skeleton. Evol Med Public Health. 2018;2018(1):167–79. https://doi.org/10.1093/emph/eoy015 .
doi: 10.1093/emph/eoy015 pubmed: 30152815 pmcid: 6101485
Stieglitz J, Trumble BC, Finch CE, Li D, Budoff MJ, Kaplan H, Gurven MD. Computed tomography shows high fracture prevalence among physically active forager-horticulturalists with high fertility. eLife. 2019;8:e48607.
pubmed: 31418688 pmcid: 6726459 doi: 10.7554/eLife.48607
Rivadeneira F, Mäkitie O. Osteoporosis and bone mass disorders: from gene pathways to treatments. Trends Endocrinol Metab. 2016;27(5):262–81.
pubmed: 27079517 doi: 10.1016/j.tem.2016.03.006
Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai R, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51(2):258–66.
pubmed: 30598549 doi: 10.1038/s41588-018-0302-x
Chen X, Hongling Y, Xijie Y. A review of the clinical, radiological and biochemical characteristics and genetic causes of high bone mass disorders. Curr Drug Targ. 2018;19(6):621–35. https://doi.org/10.2174/1389450119666180122161503 .
doi: 10.2174/1389450119666180122161503
Gregson CL, Sayers A, Lazar V, Steel S, Dennison EM, Cooper C, et al. The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: Findings from a pQCT case–control study. Bone. 2013;52(1):380–8.
pubmed: 23103330 pmcid: 3526774 doi: 10.1016/j.bone.2012.10.021
Arsuaga JL, Carretero JM, Lorenzo C, Gómez-Olivencia A, Pablos A, Rodríguez L, et al. Postcranial morphology of the middle Pleistocene humans from Sima de los Huesos, Spain. Proc Natl Acad Sci U S A. 2015;112(37):11524–9.
pubmed: 26324920 pmcid: 4577189 doi: 10.1073/pnas.1514828112
Arsuaga JL, Martínez I, Arnold LJ, Aranburu A, Gracia-Téllez A, Sharp WD, et al. Neandertal roots: cranial and chronological evidence from Sima de los Huesos. Science. 2014;344(6190):1358–63. https://doi.org/10.1126/science.1253958 .
doi: 10.1126/science.1253958 pubmed: 24948730
Rodríguez L, Carretero JM, García-González R, Arsuaga JL. Cross-sectional properties of the lower limb long bones in the Middle Pleistocene Sima de los Huesos sample (Sierra de Atapuerca, Spain). J Hum Evol. 2018;117:1–12.
pubmed: 29544620 doi: 10.1016/j.jhevol.2017.11.007
Carretero JM, Rodríguez L, García-González R, Quam RM, Arsuaga JL. Exploring bone volume and skeletal weight in the Middle Pleistocene humans from the Sima de los Huesos site (Sierra de Atapuerca, Spain). J Anat. 2018;233(6):740–54. https://doi.org/10.1111/joa.12886 .
doi: 10.1111/joa.12886 pubmed: 30280382 pmcid: 6231173
Littman J, Yang W, Olansen J, Phornphutkul C, Aaron RK. LRP5, bone mass polymorphisms and skeletal disorders. Genes (Basel). 2023;14(10):1846.
pubmed: 37895195 doi: 10.3390/genes14101846
van Meurs JBJ, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008;299(11):1277–90.
pubmed: 18349089 pmcid: 3282142 doi: 10.1001/jama.299.11.1277
Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002;70(1):11–9.
pubmed: 11741193 doi: 10.1086/338450
Gregson CL, Duncan EL. The genetic architecture of high bone mass. Front Endocrinol (Lausanne). 2020;11:595653.
pubmed: 33193107 doi: 10.3389/fendo.2020.595653
Martínez-Gil N, Ugartondo N, Grinberg D, Balcells S. Wnt pathway extracellular components and their essential roles in bone homeostasis. Genes (Basel). 2022;13(1):138.
pubmed: 35052478 doi: 10.3390/genes13010138
Ahlquist KD, Bañuelos MM, Funk A, Lai J, Rong S, Villanea FA, et al. Our tangled family tree: new genomic methods offer insight into the legacy of archaic admixture. Genome Biol Evol. 2021. https://doi.org/10.1093/gbe/evab115 .
doi: 10.1093/gbe/evab115 pubmed: 34028527 pmcid: 8480178
Medina-Gómez C, Chesi A, Heppe DHM, Zemel BS, Yin JL, Kalkwarf HJ, et al. BMD loci contribute to ethnic and developmental differences in skeletal fragility across populations: assessment of evolutionary selection pressures. Mol Biol Evol. 2015;32(11):2961–72.
pubmed: 26226985 pmcid: 4651235 doi: 10.1093/molbev/msv170
Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
pubmed: 26432245 doi: 10.1038/nature15393
Prüfer K, Racimo F, Patterson N, Jay F, Sankararaman S, Sawyer S, et al. The complete genome sequence of a Neanderthal from the Altai Mountains. Nature. 2014;505(7481):43–9.
pubmed: 24352235 doi: 10.1038/nature12886
Meyer M, Kircher M, Gansauge MT, Li H, Racimo F, Mallick S, et al. A high-coverage genome sequence from an archaic Denisovan individual. Science. 2012;338(6104):222–6.
pubmed: 22936568 pmcid: 3617501 doi: 10.1126/science.1224344
Prüfer K, de Filippo C, Grote S, Mafessoni F, Korlević P, Hajdinjak M, et al. A high-coverage Neandertal genome from Vindija Cave in Croatia. Science. 2017;358(6363):655–8.
pubmed: 28982794 pmcid: 6185897 doi: 10.1126/science.aao1887
Mafessoni F, Grote S, de Filippo C, Slon V, Kolobova KA, Viola B, et al. A high-coverage Neandertal genome from Chagyrskaya cave. Proc Natl Acad Sci U S A. 2020;117(26):15132–6.
pubmed: 32546518 pmcid: 7334501 doi: 10.1073/pnas.2004944117
Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2):1–4.
doi: 10.1093/gigascience/giab008
Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20(1):110–21.
pubmed: 19858363 pmcid: 2798823 doi: 10.1101/gr.097857.109
Browning SR, Browning BL, Zhou Y, Tucci S, Akey JM. Analysis of human sequence data reveals two pulses of archaic denisovan admixture. Cell. 2018;173(1):53-61.e9.
pubmed: 29551270 pmcid: 5866234 doi: 10.1016/j.cell.2018.02.031
Skov L, Coll Macià M, Sveinbjörnsson G, Mafessoni F, Lucotte EA, Einarsdóttir MS, et al. The nature of Neanderthal introgression revealed by 27,566 Icelandic genomes. Nature. 2020;582(7810):78–83.
pubmed: 32494067 doi: 10.1038/s41586-020-2225-9
Murga-Moreno J, Coronado-Zamora M, Bodelón A, Barbadilla A, Casillas S. PopHumanScan: the online catalog of human genome adaptation. Nucleic Acids Res. 2019;47(D1):D1080–9.
pubmed: 30335169 doi: 10.1093/nar/gky959
Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986;3(5):418–26.
pubmed: 3444411
Smith NGC, Eyre-Walker A. Adaptive protein evolution in Drosophila. Nature. 2002;415(6875):1022–4.
pubmed: 11875568 doi: 10.1038/4151022a
Fay JC, Wu CI. Hitchhiking under positive Darwinian selection. Genetics. 2000;155(3):1405–13.
pubmed: 10880498 pmcid: 1461156 doi: 10.1093/genetics/155.3.1405
Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol. 2006;4(3):e72.
pubmed: 16494531 pmcid: 1382018 doi: 10.1371/journal.pbio.0040072
Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, et al. BioMart—biological queries made easy. BMC Genomics. 2009;10(1):1–12.
doi: 10.1186/1471-2164-10-22
de Leeuw J, Mair P. Multidimensional scaling using majorization: SMACOF in R. J Stat Softw. 2009;31(3):1–30.
doi: 10.18637/jss.v031.i03
Community Ecology Package [R package vegan version 2.6-4]. 2022.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81.
pubmed: 19561590 doi: 10.1038/nprot.2009.86
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.
pubmed: 20354512 pmcid: 2855889 doi: 10.1038/nmeth0410-248
Bourhis E, Wang W, Tam C, Hwang J, Zhang Y, Spittler D, et al. Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6. Structure. 2011;19(10):1433–42.
pubmed: 21944579 doi: 10.1016/j.str.2011.07.005
Cheng Z, Biechele T, Wei Z, Morrone S, Moon RT, Wang L, et al. Crystal structures of the extracellular domain of LRP6 and its complex with DKK1. Nat Struct Mol Biol. 2011;18(11):1204–10.
pubmed: 21984209 pmcid: 3249237 doi: 10.1038/nsmb.2139
Holdsworth G, Slocombe P, Doyle C, Sweeney B, Veverka V, Le Riche K, et al. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of wnt co-receptors. J Biol Chem. 2012;287(32):26464–77.
pubmed: 22696217 pmcid: 3410989 doi: 10.1074/jbc.M112.350108
Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779–815.
pubmed: 8254673 doi: 10.1006/jmbi.1993.1626
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9.
pubmed: 21546353 pmcid: 3203626 doi: 10.1093/molbev/msr121
Shen M, Sali A. Statistical potential for assessment and prediction of protein structures. Prot Sci. 2006;15(11):2507–24.
doi: 10.1110/ps.062416606
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.
pubmed: 29788355 pmcid: 6030848 doi: 10.1093/nar/gky427
Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963;7(1):95–9.
pubmed: 13990617 doi: 10.1016/S0022-2836(63)80023-6
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12.
pubmed: 15264254 doi: 10.1002/jcc.20084
Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33(suppl_2):W282-388.
Balemans W, Piters E, Cleiren E, Ai M, Van Wesenbeeck L, Warman ML, et al. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif Tissue Int. 2008;82(6):445–53.
pubmed: 18521528 doi: 10.1007/s00223-008-9130-9
Quintana-Murci L. Understanding rare and common diseases in the context of human evolution. Genome Biol. 2016;17(1):1–14.
doi: 10.1186/s13059-016-1093-y
Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179–92. https://doi.org/10.1038/nm.3074 .
doi: 10.1038/nm.3074 pubmed: 23389618
Arciero E, Biagini SA, Chen Y, Xue Y, Luiselli D, Tyler-Smith C, et al. Genes regulated by vitamin D in bone cells are positively selected in East Asians. PLoS ONE. 2015;10(12):e0146072.
pubmed: 26719974 pmcid: 4697808 doi: 10.1371/journal.pone.0146072
Murphy DA, Elyashiv E, Amster G, Sella G. Broad-scale variation in human genetic diversity levels is predicted by purifying selection on coding and non-coding elements. Elife. 2023;12:e76065.
pubmed: 36196994 pmcid: 10299832 doi: 10.7554/eLife.76065
Patel MS, Karsenty G. Regulation of bone formation and vision by LRP5. N Engl J Med. 2002;346(20):1572–4.
pubmed: 12015398 doi: 10.1056/NEJM200205163462011
Fenderico N, van Scherpenzeel RC, Goldflam M, Proverbio D, Jordens I, Kralj T, et al. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. Nat Commun. 2019;10(1):1–13.
doi: 10.1038/s41467-018-08172-z
Martínez-Gil N, Roca-Ayats N, Atalay N, Pineda-Moncusí M, Garcia-Giralt N, Van Hul W, et al. Functional assessment of coding and regulatory variants from the DKK1 locus. JBMR Plus. 2020;4(12):e10423.
pubmed: 33354644 pmcid: 7745885 doi: 10.1002/jbm4.10423
Bourhis E, Tam C, Franke Y, Bazan JF, Ernst J, Hwang J, et al. Reconstitution of a Frizzled8·Wnt3a·LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem. 2010;285(12):9172–9.
pubmed: 20093360 pmcid: 2838336 doi: 10.1074/jbc.M109.092130

Auteurs

Neus Roca-Ayats (N)

Departament de Genètica, Microbiologia i Estadística and IBUB, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.

Iago Maceda (I)

CNAG, Centre Nacional d'Analisi Genòmic, C/ Baldiri I Reixach 4, 08028, Barcelona, Spain.
Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Carlos David Bruque (CD)

Unidad de Conocimiento Traslacional Hospitalaria Patagónica, Hospital de Alta Complejidad El Calafate - S.A.M.I.C., Santa Cruz, Argentina.

Núria Martínez-Gil (N)

Departament de Genètica, Microbiologia i Estadística and IBUB, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.

Natàlia Garcia-Giralt (N)

Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, Departament de Genètica, Microbiologia i Estadística, UB, Barcelona, Spain.

Mónica Cozar (M)

Departament de Genètica, Microbiologia i Estadística and IBUB, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.

Leonardo Mellibovsky (L)

Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, Barcelona, Spain.

Wim Van Hul (W)

Center of Medical Genetics, University of Antwerp, 2650, Antwerp, Belgium.

Oscar Lao (O)

Institute of Evolutionary Biology, CSIC-Universitat Pompeu Fabra, 08003, Barcelona, Spain. oscar.lao@ibe.upf-csic.es.

Daniel Grinberg (D)

Departament de Genètica, Microbiologia i Estadística and IBUB, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.

Susanna Balcells (S)

Departament de Genètica, Microbiologia i Estadística and IBUB, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain.
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH